Back to search

Article

Long Non-Coding RNA ANRIL Promotes Doxorubicin Resistance in Triple-Negative Breast Cancer via Suppressing Glycolysis Through the MicroRNA-125a/ENO Pathway

2021-11-23

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Breast cancer is the main cause of death among women worldwide. More and more long non-coding RNAs (lncRNAs) have been identified as oncogenes or tumor suppressors during cancer development. However, whether ANRIL is involved in drug resistance in triple-negative breast cancer (TNBC) has not been investigated. <bold>Methods</bold>Luciferase reporter assay was cond...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f6f15dd-21b0-54ff-856a-b3dfdd3fe31e
DOI
10.21203/rs.3.rs-1062354/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Long Non-Coding RNA ANRIL Promotes Doxorubicin Resistance in Triple-Negative Breast Cancer via Suppressing Glycolysis Through the MicroRNA-125a/ENO PathwayDOI 10.21203/rs.3.rs-1062354/v1
Select a neighboring publication to make it the new centre.